ClearAlpha Technologies’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

ClearAlpha Technologies’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-102,350	Closed	-$2.18M	–	339
2024 Q1	$2.18M	Buy	+102,350	New	+$1.22M	0.92%	18

ClearAlpha Technologies's FUSN Position: Q2 2024 in Review

ClearAlpha Technologies sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 102,350 shares — an estimated $2.18M sold.

ClearAlpha Technologies first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $2.18M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

ClearAlpha Technologies reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
ClearAlpha Technologies sold 102,350 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.18M.
ClearAlpha Technologies first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
ClearAlpha Technologies's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.18M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on ClearAlpha Technologies's 13F filing for Q2 2024, filed 13 Aug 2024.